Lineage Cell Therapeutics, Inc. · AMEX:LCTX
Lineage Cell Therapeutics, Inc. shareholders
As of Jun 30, 2026, 127 institutions reported holding Lineage Cell Therapeutics, Inc., 46.1% of its shares. Largest: Broadwood Capital Inc, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Lineage Cell Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Broadwood Capital Inc | 49.6M | 19.6% | no change | Aug 14, 2026 |
| BlackRock | 13.2M | 5.2% | +9.32M | Aug 7, 2026 |
| Vanguard | 12.1M | 4.8% | +2.35M | Aug 13, 2026 |
| Defender Capital, LLC. | 6.6M | 2.6% | −131K | Jul 9, 2026 |
| Geode Capital | 5.3M | 2.1% | +2.78M | Aug 12, 2026 |
| Raffles Associates LP | 5.2M | 2.1% | −165K | Aug 17, 2026 |
| Fifth Third Bancorp | 4.6M | 1.8% | no change | Aug 5, 2026 |
| Millennium | 3.02M | 1.2% | −2.54M | Aug 14, 2026 |
| State Street | 2.31M | 0.92% | +1.22M | Aug 7, 2026 |
| Northern Trust | 1.66M | 0.66% | +1.16M | Aug 13, 2026 |